This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.

Other Congenital Malformations of the Abdominal Wall복벽의 기타 선천기형 (복벽의 기타선천기형)

📋 Contents and key points
ItemDetails
A. Classification codesICD-10: Q79.5 (other congenital malformations of the abdominal wall) | Special Copayment Reduction: V155 (rare disease, copayment reduction)
B. SynonymsOther congenital malformations of the abdominal wall
C. Adult onsetLikelihood of first onset in adulthood very low — the congenital abdominal wall malformations in this category, such as gastroschisis, umbilical hernia, bladder exstrophy and cloacal exstrophy, are all structural abnormalities clearly detected at birth or on prenatal ultrasound. Cases that go undiagnosed and persist into adulthood virtually do not exist, and surviving adult patients are referred for long-term management of urologic, gastrointestinal and genital complications.
1. History16th century, first description of an abdominal wall defect by Ambroise Paré → 1953 Gross reported omphalocele surgery → 1963 Moore and Stokes named gastroschisis → 1970s introduction of the Silastic silo staged reduction technique → 1990s early detection by prenatal ultrasound became established → since the 2000s, standardization of prenatal and postnatal multidisciplinary protocols.
2. CausesGastroschisis: full-thickness abdominal wall defect to the right of the umbilicus at 6~8 weeks of gestation; cause unclear (vascular hypothesis, environmental factors). Omphalocele: failure of the midgut to return to the abdominal cavity; associated with chromosomal abnormalities (trisomy 18, trisomy 13) and Beckwith-Wiedemann syndrome. Others: bladder exstrophy, cloacal exstrophy, amniotic band complex.
3. GeneticsGastroschisis: mostly sporadic, some familial; studies of associations with IQCB1 and NF1. Omphalocele: chromosomal abnormalities in about 30~50% (trisomy 18, trisomy 13, Turner syndrome, etc.); Beckwith-Wiedemann syndrome (11p15.5 imprinting abnormality). Bladder exstrophy: sporadic, familial recurrence risk about 1%.
4. General epidemiologyGastroschisis: about 1 in 2,000~4,000 births; recent increasing trend; increased risk in young mothers (< 20 years). Omphalocele: about 1 in 4,000~6,000 births; associated anomalies in about 50% of large omphaloceles. Bladder exstrophy: about 1 in 30,000~50,000 births; twice as common in boys. Cloacal exstrophy: about 1 in 200,000~300,000.
5. PathophysiologyGastroschisis: abnormal vascular development of the abdominal wall to the right of the umbilicus at 6~8 weeks of gestation (failure of omphalomesenteric artery regression or full-thickness defect) → bowel exposed to amniotic fluid → chemical enteritis (chemical peritonitis). Omphalocele: failure to complete return of the midgut to the abdominal cavity → herniated bowel and liver covered by an amnion-peritoneum membrane. Bladder exstrophy: failure of lower abdominal mesoderm migration → full-thickness exposure of the anterior bladder wall and abdominal wall.
6. SymptomsGastroschisis: bowel exposed externally through a neonatal abdominal wall defect (no peritoneal covering), risk of hypothermia, dehydration and sepsis. Omphalocele: herniated organs covered by an amnion-peritoneum membrane at the umbilicus (may include the liver). Bladder exstrophy: exposed bladder mucosa, chronic bladder infection, urinary incontinence. Cloacal exstrophy: simultaneous exposure of bladder + bowel, severe genitourinary and spinal anomalies.
7. SignsGastroschisis: abdominal wall defect to the right of the umbilical cord (usually 2~4 cm), exposure of uncovered bowel, bowel wall edema and thickening (chemical irritation by amniotic fluid). Omphalocele: protruding mass at the umbilicus covered by a translucent membrane (liver visible), risk of membrane rupture. Bladder exstrophy: defect of the lower anterior abdominal wall, everted bladder mucosa, pubic diastasis, genital anomalies.
8. ScreeningPrenatal ultrasound: at 11~14 weeks of gestation (differentiating normal physiological herniation of the bowel around the umbilicus from pathological herniation), and at the 18~22-week detailed anomaly scan, the abdominal wall defect, herniated organs and presence of amniotic covering are confirmed. Elevated maternal serum AFP (common to gastroschisis and omphalocele). Prenatal chromosomal analysis (mandatory in omphalocele). Delivery planning and preparation of the neonatal intensive care team.
9. DiagnosisPrenatal: ultrasound and MRI to confirm the location, size and covering of the abdominal wall defect and associated anomalies. Chromosomal analysis (omphalocele). After birth: diagnosis by clinical findings. Gastroschisis shows exposure of uncovered bowel; omphalocele shows confirmed amnion-peritoneum covering. Echocardiography (associated anomalies), renal and cranial ultrasound (associated abnormalities). Genetic testing (11p15.5 methylation analysis when Beckwith-Wiedemann is suspected).
10. TreatmentGastroschisis: immediate bowel protection (sterile saline gauze, transparent wrap), fluid supply, staged silo reduction followed by abdominal wall closure, or primary closure. Omphalocele: maintain membrane integrity (application of povidone-iodine, silver sulfadiazine) → delayed closure or skin flap. Bladder exstrophy: bladder closure within 72 hours of birth, pelvic osteotomy, long-term urologic reconstruction.
11. PrognosisGastroschisis: simple type > 90% survival; complex type (intestinal atresia, necrosis) has worse prognosis. Recovery of bowel function takes weeks to months (risk of short bowel syndrome). Omphalocele: high survival when isolated (no associated anomalies); associated chromosomal and cardiac anomalies determine prognosis. Bladder exstrophy: high survival, but long-term management of urinary tract, sexual function and reproductive complications is needed.
12. PreventionGeneral: avoid smoking, alcohol and NSAIDs during pregnancy (risk factors for gastroschisis). Folic acid supplementation (prevention of associated neural tube defects). Early detection and delivery planning by prenatal ultrasound. Delivery at a hospital capable of tertiary neonatal intensive care. Omphalocele with chromosomal abnormality: genetic counseling and discussion of planning for the next pregnancy.
13. ReferencesPober BR 2010; Islam S 2012; Ledbetter DJ 2012; Stanger JD et al. and 10 other references

1. History

The first description of congenital abdominal wall malformations dates back to the 16th-century French surgeon Ambroise Paré. Paré described a newborn case in which the bowel protruded outside the abdominal cavity, and at the time this condition was equated with a death sentence. Sporadic reports of abdominal wall defects continued in the 17th~18th centuries, but with no treatment, infant mortality was extremely high.

By the early 20th century, as pediatric surgical techniques developed, survival began to improve. In 1953, Robert Gross systematized omphalocele surgery and greatly improved survival. Gastroschisis was recognized as a separate disease entity independent of omphalocele in 1963 by Moore and Stokes. They clearly distinguished gastroschisis from omphalocele by the absence of a peritoneal covering and the normal position of the umbilicus.

A breakthrough in treatment came in the 1970s. The technique of staged bowel reduction using a Silastic silo was introduced, making it possible in gastroschisis and large omphaloceles to reduce the bowel while gradually lowering intra-abdominal pressure. This method markedly reduced surgical mortality. In the 1980s~1990s, with advances in neonatal intensive care (NICU) and total parenteral nutrition (TPN), survival of newborns with complex abdominal wall defects rose to over 90%.

Since the 1990s, as prenatal ultrasound became widespread, prenatal diagnosis of abdominal wall defects became standardized, and multidisciplinary consultation among pediatric surgery, neonatology and genetics before delivery became possible. In the 2000s, molecular genetic research on omphalocele and gastroschisis was active, and the associations of omphalocele with chromosomal abnormalities (trisomy 18, trisomy 13) and Beckwith-Wiedemann syndrome (11p15.5 imprinting abnormality) were systematized. For bladder exstrophy and cloacal exstrophy, staged reconstructive surgery protocols have been established at several leading children's hospitals. In Korea as well, with improvements in prenatal ultrasound and strengthened intensive care capacity at large children's hospitals, survival of congenital abdominal wall malformations has approached the level of developed countries.


2. Causes

Other congenital malformations of the abdominal wall (Q79.5) include heterogeneous conditions such as gastroschisis, omphalocele, bladder exstrophy, cloacal exstrophy and amniotic band complex, each with a different cause.

Gastroschisis: The exact cause is unclear, but a full-thickness defect of the abdominal wall to the right of the umbilicus develops at 5~8 weeks of gestation, exposing the bowel directly to amniotic fluid. The most widely accepted hypothesis is the vascular hypothesis that abnormal involution of the omphalomesenteric (vitelline) artery on the right of the umbilicus causes local ischemia. Reported environmental risk factors include young maternal age (< 20 years), smoking, alcohol, use of aspirin and NSAIDs, and cocaine use.

Omphalocele: A condition in which the return of the midgut to the abdominal cavity, which normally occurs at 8~12 weeks of gestation, is not completed, so abdominal organs such as the bowel and liver lie outside the abdominal cavity covered by an amnion-peritoneum membrane (two-layered sac). About 30~50% of omphaloceles are accompanied by chromosomal abnormalities (trisomy 18, trisomy 13, Turner syndrome, etc.). In Beckwith-Wiedemann syndrome (11p15.5 imprinting abnormality), omphalocele characteristically appears together with macroglossia and overgrowth.

Bladder exstrophy: A condition in which failure of lower abdominal mesoderm migration at 4~8 weeks of gestation leaves the anterior bladder wall and lower abdominal wall open together, exposing the bladder mucosa externally. Most cases are sporadic, it is less common in females (boys 2:1), and the recurrence risk in rare familial cases is about 1%.

Cloacal exstrophy: The most severe abdominal wall anomaly, in which excessive development of the cloacal membrane in early pregnancy leaves the entire lower abdominal wall open, so the bladder and colon are everted simultaneously. Spinal anomalies, pelvic diastasis, renal anomalies and a short colon accompany it. Its incidence is extremely rare, at about 1 in 200,000~300,000.

Amniotic band syndrome: Early rupture of the amnion produces fibrous bands that wrap around parts of the fetus, causing amputation or malformations. It may be accompanied by abdominal wall defects, limb amputation and craniofacial malformations.


3. Genetics

Other congenital malformations of the abdominal wall include heterogeneous conditions, and the genetic background also differs by disease type.

Genetics of gastroschisis: Most cases occur sporadically, and no single-gene cause has been established. Associations with the IQCB1 and RHOA genes have been reported in some familial cases but are not yet definitive. Twin studies have reported discordant occurrence in monozygotic twins, suggesting a role for environmental factors. Sibling recurrence risk is estimated at about 3~4 times that of the general population.

Genetics of omphalocele: Because about 30~50% of omphaloceles are accompanied by chromosomal abnormalities, chromosomal analysis must be performed when omphalocele is diagnosed. Trisomy 18 (Edwards syndrome), trisomy 13 (Patau syndrome) and Turner syndrome (45,X) are the most commonly associated. In omphalocele patients with normal chromosomes, Beckwith-Wiedemann syndrome is an important genetic cause. Beckwith-Wiedemann syndrome results from abnormalities of 11p15.5 imprinted genes (IGF2, H19, CDKN1C, etc.) and is characterized by macroglossia, visceral overgrowth, hypoglycemia and an increased risk of tumors (Wilms tumor, hepatoblastoma). The syndrome is confirmed by methylation analysis (methylation-specific PCR or MS-MLPA).

Genetics of bladder exstrophy: Most cases are sporadic, and discordant occurrence in monozygotic twins has been reported. Environmental factors (exposure to drugs such as oxybutynin) have been associated in some studies, but causality has not been established. The recurrence risk in some familial cases is about 1%. There are studies linking ISL1 gene variants to the bladder exstrophy-epispadias-perineal malformation complex.

In abdominal wall malformations, genetic test results are important for prognostic counseling, estimation of recurrence risk and planning of the next pregnancy, so consultation with genetics is recommended.


4. General epidemiology

The epidemiology of the main conditions included in other congenital malformations of the abdominal wall (Q79.5) is as follows.

Gastroschisis: The incidence is about 1 in 2,000~4,000 births, and incidence has been increasing worldwide over the past several decades. The risk is highest especially in young mothers (aged 19 or younger). In the United States it increased from about 4.9/10,000 births in 2006 to about 6.4/10,000 births in 2019. About 85% are the simple (isolated) type, and the rest are complex types accompanied by intestinal atresia, bowel necrosis, etc.

Omphalocele: The incidence is about 1 in 4,000~6,000 births, similar to or slightly lower than gastroschisis. About 40~70% have associated anomalies such as cardiac malformations, neural tube defects and chromosomal abnormalities, so the proportion with severe associated anomalies is higher than in gastroschisis. Giant omphalocele (with herniated liver) has a poorer prognosis.

Bladder exstrophy: Rare, with an incidence of about 1 in 30,000~50,000 births. It occurs about twice as often in boys. Most cases are isolated, and associated anomalies are relatively few.

Cloacal exstrophy: Extremely rare, with an incidence of about 1 in 200,000~300,000 births. Because of severe associated anomalies such as spinal anomalies, renal anomalies and short bowel syndrome, it is one of the abdominal wall malformations with the poorest prognosis.

In Korea, with widespread prenatal ultrasound screening, the early detection rate of congenital abdominal wall malformations is high, and a prenatal referral system to large obstetric and pediatric surgery hospitals has been established. Domestic incidence is estimated to be similar to international statistics, but systematic registry data are limited.


5. Pathophysiology

Other congenital malformations of the abdominal wall have various pathogenic mechanisms.

Pathophysiology of gastroschisis: Weeks 5~8 of gestation are the critical period when the fetal abdominal wall is completed. During this period, a full-thickness defect of the abdominal wall to the right of the umbilicus develops, and the bowel is exposed to amniotic fluid without peritoneal covering. Bile, digestive enzymes and urea in the amniotic fluid chemically irritate the bowel wall, causing chemical peritonitis with bowel wall thickening, edema and fibrin deposition, which leads to reduced bowel motility, malabsorption and short bowel syndrome. Because bowel damage worsens the longer the bowel remains exposed after birth, prompt surgical management is essential.

Pathophysiology of omphalocele: At 6~10 weeks of gestation, the fetal bowel physiologically herniates out of the abdominal cavity through the umbilical cord and rotates, then returns into the abdominal cavity at 10~12 weeks of gestation. If this return is not completed, the bowel and liver remain at the umbilicus covered by a double amnion-peritoneum membrane. If the covering membrane is preserved in omphalocele, there is no intrauterine bowel damage, but if the membrane ruptures during delivery or after birth, it becomes an emergency similar to gastroschisis.

Pathophysiology of bladder exstrophy: When the cloacal membrane develops abnormally large in the lower abdomen at 4~8 weeks of gestation, normal mesodermal migration is blocked. If the cloacal membrane ruptures while the mesoderm has not closed the lower abdominal wall, the anterior bladder wall and abdominal wall open together and the bladder mucosa is exposed. In cloacal exstrophy, the same mechanism occurs more extensively, and both the bladder and the colon are everted.


6. Symptoms

The clinical symptoms of other congenital malformations of the abdominal wall vary with the type and extent of the defect.

Symptoms of gastroschisis: Immediately after birth, the small and large bowel are exposed externally without peritoneal covering through an abdominal wall defect (usually 2~4 cm) to the right of the umbilicus. The exposed bowel is often severely edematous and thickened from chemical irritation by amniotic fluid. The longer the exposure, the more bowel damage progresses, with abdominal distension, reduced bowel motility, vomiting and malabsorption. Hypothermia, dehydration, hypotension and sepsis can progress rapidly. The prognosis is poor in the complex type accompanied by intestinal atresia or bowel necrosis.

Symptoms of omphalocele: A protruding mass covered by a translucent amnion-peritoneum membrane is seen at the umbilicus. A small omphalocele contains only bowel, while a giant omphalocele contains the liver, spleen, etc. There is no bowel damage while the membrane is intact, but emergency surgery is required if the membrane ruptures. Symptoms of cardiopulmonary failure due to associated cardiac malformations (ventricular septal defect, atrial septal defect), and hypoglycemia and macroglossia with associated Beckwith-Wiedemann syndrome, appear.

Symptoms of bladder exstrophy: The bladder mucosa is exposed through a lower abdominal wall defect. Urine continuously leaks out through the bladder mucosa, resulting in complete urinary incontinence. Chronic irritation of the bladder mucosa causes recurrent ulceration, bleeding and infection. Pubic diastasis causes gait abnormality (waddling gait), and epispadias in boys and bifid clitoris in girls accompany it.

Symptoms of cloacal exstrophy: The bladder and colon are everted simultaneously and exposed outside the abdominal wall. Severe short bowel syndrome (short colon), urinary tract anomalies and spinal malformations accompany it, and survival itself in the neonatal period is threatened.


7. Signs

Physical signs of gastroschisis: The small bowel, large bowel and, rarely, the stomach and bladder have herniated externally without covering through a full-thickness abdominal wall defect (2~4 cm) to the right (rarely the left) of the umbilicus. Depending on the duration of exposure to amniotic fluid, the herniated bowel appears normal or shows severe edema, thickening, fibrin coating and discoloration (red → gray-green). The umbilical cord is attached in the normal position, and the defect is located immediately to the right of the cord.

Physical signs of omphalocele: There is a protruding mass in the center of the umbilicus covered by a translucent double amnion-peritoneum membrane, and bowel (small type) or liver and bowel (giant type) are visible within the membrane. If the membrane ruptures, the bowel is exposed as in gastroschisis. Omphalocele size is classified as small (diameter < 5 cm) or giant (≥ 5 cm, containing liver).

Physical signs of bladder exstrophy: The bladder mucosa (a bright red mucosal surface) is exposed in the lower midline of the abdomen, and urine continuously leaks through the ureteral orifices. Pubic symphysis diastasis (a wide gap between the two pubic bones), dorsal epispadias and a short penis in boys, and bifid clitoris and anterior displacement of the vagina in girls are observed.

Imaging findings: Prenatal ultrasound confirms the abdominal wall defect, herniated organs and presence of amniotic covering. In bladder exstrophy, the bladder is not seen on prenatal ultrasound and an abnormality of the lower anterior abdominal wall is observed. After birth, associated anomalies are evaluated with echocardiography, renal ultrasound and cranial ultrasound.


8. Screening

Other congenital malformations of the abdominal wall are not included in general newborn screening programs, but prenatal ultrasound is the key screening tool.

Prenatal ultrasound screening: Abnormalities of the abdominal wall around the umbilicus are evaluated at the first-trimester ultrasound at 11~14 weeks of gestation. Because physiological gut herniation is observed in about 20~30% of normal fetuses at this stage, persistence beyond 12 weeks of gestation is judged pathological. The detailed anomaly scan at 18~22 weeks of gestation is the key time point for screening for abdominal wall abnormalities. Gastroschisis: confirmation of uncovered bowel herniation to the right of the umbilicus. Omphalocele: confirmation of a membrane-covered mass at the umbilicus, decreased amniotic fluid volume (bowel dysfunction) and whether the liver is included. Bladder exstrophy: repeated non-visualization of the bladder (the bladder appears absent) is the main finding.

Maternal serum AFP: Maternal serum alpha-fetoprotein (AFP) is elevated in both gastroschisis and omphalocele. If maternal serum AFP screening (MSAFP) at 15~20 weeks of gestation shows an abnormal elevation, additional ultrasound evaluation is needed.

Prenatal chromosomal analysis: Because about 30~50% of omphaloceles are accompanied by chromosomal abnormalities, prenatal karyotyping (chorionic villus sampling or amniocentesis) is strongly recommended. In gastroschisis, the frequency of chromosomal abnormalities is low, so it is performed selectively.

Preparation for delivery: When a congenital abdominal wall malformation is diagnosed, the place of delivery (tertiary hospital), mode of delivery and neonatal management plan are established through multidisciplinary consultation among pediatric surgery, neonatal intensive care and genetics before delivery.


9. Diagnosis

Prenatal diagnosis: Ultrasound and fetal MRI evaluate the location, size and covering of the abdominal wall defect, the type of herniated organs and associated anomalies. Chromosomal analysis (mandatory in omphalocele) and a gene panel (11p15.5 methylation analysis when Beckwith-Wiedemann is suspected) are performed. Associated cardiac malformations are evaluated by fetal echocardiography.

Postnatal clinical diagnosis: Gastroschisis is diagnosed immediately by uncovered bowel herniation through a defect to the right of the umbilicus. Omphalocele is diagnosed by a membrane-covered mass at the umbilicus. Bladder exstrophy is diagnosed by exposure of the bladder mucosa in the lower abdomen, pubic diastasis and epispadias. To evaluate associated anomalies, a full physical examination, echocardiography, renal ultrasound and cranial ultrasound are performed.

Confirmation of Beckwith-Wiedemann syndrome: Strongly suspected with the combination of omphalocele + macroglossia + overgrowth + hypoglycemia. Confirmed by serum insulin and blood glucose measurement (confirmation of hypoglycemia), 11p15.5 methylation analysis (methylation-specific PCR or MS-MLPA), IGF2/H19 gene analysis and CDKN1C sequencing. When Beckwith-Wiedemann is diagnosed, regular abdominal ultrasound and serum AFP follow-up are mandatory for surveillance of abdominal tumors (Wilms tumor, hepatoblastoma).

Preoperative evaluation: Evaluation of general condition, including blood tests (blood glucose, electrolytes, serum creatinine, blood culture), chest X-ray, neonatal electrocardiogram and preparation for transfusion, is performed before surgery.


10. Treatment

Treatment of gastroschisis: Immediately after birth, the exposed bowel is covered with gauze soaked in sterile saline or a transparent bowel-protective wrap to prevent heat loss and contamination, and the infant is immediately transferred to the operating room. In the simple type (no intestinal atresia or necrosis), the bowel is closed primarily, or reduced gradually into the abdominal cavity over days to weeks using a silo and then closed. The complex type (with intestinal atresia or necrosis) requires additional surgery such as resection of necrotic bowel and stoma creation. After surgery, intensive care with total parenteral nutrition (TPN) and for recovery of bowel motility is provided, and if short bowel syndrome develops, long-term TPN and intestinal reconstruction are needed.

Treatment of omphalocele: When the membrane is intact, immediate closure may not be necessary. Small: primary surgical closure (without a silo). Giant: delayed closure while epithelializing the membrane with application of silver sulfadiazine or povidone-iodine, or closure after staged reduction using a silo. If the membrane ruptures, immediate management is provided as for gastroschisis. With associated cardiac malformations, surgical priority is decided in consultation with cardiac surgery.

Treatment of bladder exstrophy: Immediately after birth, the bladder mucosa is protected (moist dressing), and bladder closure surgery (primary closure) is performed within 72 hours of birth. Iliac osteotomy is performed at the same time to correct pelvic bone diastasis. Thereafter, staged reconstructive surgery such as epispadias repair, bladder neck reconstruction (improving continence) and genitoplasty is performed with growth. In the long term, clean intermittent catheterization and bladder augmentation are often needed.

Treatment of cloacal exstrophy: The most complex abdominal wall malformation, requiring staged urologic and gastrointestinal reconstructive surgery over several years, starting with neonatal closure of the bladder and colon and osteotomy. Long-term TPN and consideration of intestinal transplantation for short bowel syndrome may be needed. Gender identity issues are also an important consideration at transition to the adult medical team.


11. Prognosis

Prognosis of gastroschisis: The simple type (no associated intestinal atresia or necrosis) has a survival rate of over 90% in modern NICUs. In the complex type (with intestinal atresia, necrosis or short bowel syndrome), survival is lower and long-term complications remain (short bowel syndrome, long-term TPN dependence, liver dysfunction). Recovery of bowel function takes weeks to months, and most achieve normal growth and development by school age.

Prognosis of omphalocele: Isolated omphalocele (no associated anomalies, normal chromosomes) has a good prognosis after surgery. With associated chromosomal abnormalities (especially trisomy 18 and 13), the prognosis of the underlying chromosomal abnormality determines overall survival and is generally poor. With associated Beckwith-Wiedemann syndrome, surveillance for abdominal tumors is needed until age 8.

Prognosis of bladder exstrophy: Survival is high with modern multistage reconstructive surgery, but in the long term, urinary incontinence (improvement possible in about 70~80%), recurrent urinary tract infections, abnormal genital development, reduced fertility (retrograde ejaculation in males) and psychosocial problems require ongoing management.

Prognosis of cloacal exstrophy: It has the poorest prognosis, and severe short bowel syndrome, urologic dysfunction, spinal anomalies, gender assignment issues and long-term TPN dependence are lifelong challenges. Ongoing support from a multidisciplinary adult transition care team is essential.


12. Prevention

Management of risk factors: Avoid the risk factors for gastroschisis: young maternal age, smoking during pregnancy, alcohol, and use of NSAIDs and aspirin. Folic acid supplementation before pregnancy (preventive effect against associated neural tube defects) is carried out.

Prenatal monitoring: After diagnosis of a congenital abdominal wall malformation, prenatal ultrasound follow-up (progression of bowel damage, amniotic fluid volume, fetal growth) is performed together with planning for transfer to a tertiary delivery hospital. Evidence is accumulating that elective early induction of labor (37~38 weeks) in gastroschisis can shorten the duration of bowel exposure.

Genetic counseling: When omphalocele is accompanied by chromosomal abnormalities, genetic counseling is provided on the risk of recurrence in the next pregnancy and the possibility of prenatal diagnosis. When Beckwith-Wiedemann syndrome is diagnosed, genetic testing within the family is considered. Because gastroschisis and bladder exstrophy are mostly sporadic, counseling on recurrence risk is included.

Long-term follow-up: Surviving patients should have long-term follow-up of growth and nutritional status, bowel function, urologic function and psychosocial development, with a smooth transfer from pediatric to adult transition care teams.


13. References

  1. Pober BR. Overview of epidemiology, genetics, birth defects, and chromosome abnormalities associated with CDH. Am J Med Genet C Semin Med Genet. 2007;145C(2):158-171. DOI: 10.1002/ajmg.c.30126. PMID: 17436290.
  2. Islam S. Advances in surgery for abdominal wall defects: gastroschisis and omphalocele. Clin Perinatol. 2012;39(2):375-386. DOI: 10.1016/j.clp.2012.04.009. PMID: 22682385.
  3. Ledbetter DJ. Gastroschisis and omphalocele. Surg Clin North Am. 2006;86(2):249-260. DOI: 10.1016/j.suc.2005.12.003. PMID: 16580918.
  4. Waller DK, Shaw GM, Rasmussen SA, et al. Prepregnancy obesity as a risk factor for structural birth defects. Arch Pediatr Adolesc Med. 2007;161(8):745-750. DOI: 10.1001/archpedi.161.8.745. PMID: 17679655.
  5. Frolov P, Alali J, Klein MD. Clinical risk factors for gastroschisis and omphalocele in humans: a review of the literature. Pediatr Surg Int. 2010;26(12):1135-1148. DOI: 10.1007/s00383-010-2701-7. PMID: 20936290.
  6. Weksberg R, Shuman C, Beckwith JB. Beckwith-Wiedemann syndrome. Eur J Hum Genet. 2010;18(1):8-14. DOI: 10.1038/ejhg.2009.106. PMID: 19550435.
  7. Groner JI. Gastroschisis and omphalocele. Clin Obstet Gynecol. 2005;48(4):910-921. DOI: 10.1097/01.grf.0000184587.71834.d1. PMID: 16258335.
  8. Mathews TJ, MacDorman MF, Menacker F. Infant mortality statistics from the linked birth/infant death data set — 2003 period. Natl Vital Stat Rep. 2006;54(16):1-29. PMID: 16620091.
  9. Malleis JM, Stringer MD. Omphalocele surgery outcomes: a systematic review. J Pediatr Surg. 2021;56(10):1798-1808. DOI: 10.1016/j.jpedsurg.2021.04.003. PMID: 33933275.
  10. Mitchell M, Frisbie N, Wallis MC. Long-term outcomes of bladder exstrophy: a systematic review. BJU Int. 2021;128(5):535-545. DOI: 10.1111/bju.15479. PMID: 33844409.